Symbio Pharmaceuticals
(OTC: SYMQY)
|
1:42 PM UTC, 05/20/24 | |||
---|---|---|---|---|
Last: $1.21 | Change: +0.00 | %Change: +0.00% | Volume: 100 |
Open: | $ 1.21 | Volume: | 100 | |
---|---|---|---|---|
High: | $ 1.21 | Yield(%) | n/a | |
Low: | $ 1.21 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 26,113.00 | |
EPS ($) | n/a | Shares Out: | 26,113.00 |
% Price Change (last 4 weeks): | n/a |
---|---|
% Price Change (last 13 weeks): | n/a |
% Price Change (last 26 weeks): | n/a |
% Price Change (last 52 weeks): | n/a |
% Price Change (year to date): | n/a |
Return on Equity (%): | n/a |
---|---|
Return on Assets (%): | n/a |
Return on Invested Capital (%): | n/a |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | n/a |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $2.92 |
52-wk low: | $1.21 |
Bid: | $n/a |
Ask: | $n/a |
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan.
|
Symbio Pharmaceuticals
Toranomon 30 Mori Building 3-2-2 Toranomon Minato-Ku Tokyo TY 105-0001 Phone: 81.3.5472.1125 Fax: 81.3.5472.3054 http://www.symbiopharma.com |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | n/a |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | n/a |
Cash Flow ($): | n/a |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | n/a |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | n/a |
---|---|
Current Ratio (x): | n/a |
LT Debt/Equity (x): | n/a |
Total Debt/Equity (x): | n/a |